RTI Surgical (RTIX) reached a global milestone of >8 million biologic implants processed through proprietary sterilization, with no confirmed incidence of implant-associated infection. The company is also celebrating its 20th anniversary in biologic implant distribution.
RTIX tissue-specific sterilization services include BioCleanse® for grafts used in orthopaedic, spine and sports medicine procedures; Cancelle® SP DBM for bone void fillers in spine, trauma, joint reconstruction, extremities and dental surgeries; and Tutoplast®, for hernia repair, dental and other procedures.
RTI Surgical (RTIX) reached a global milestone of >8 million biologic implants processed through proprietary sterilization, with no confirmed incidence of implant-associated infection. The company is also celebrating its 20th anniversary in biologic implant distribution.
RTIX tissue-specific sterilization services include BioCleanse® for...
RTI Surgical (RTIX) reached a global milestone of >8 million biologic implants processed through proprietary sterilization, with no confirmed incidence of implant-associated infection. The company is also celebrating its 20th anniversary in biologic implant distribution.
RTIX tissue-specific sterilization services include BioCleanse® for grafts used in orthopaedic, spine and sports medicine procedures; Cancelle® SP DBM for bone void fillers in spine, trauma, joint reconstruction, extremities and dental surgeries; and Tutoplast®, for hernia repair, dental and other procedures.
Copy to clipboard 
